Neurosurgical grade biomaterial, DuraGen TM , offers a promising matrix for protected delivery of neural stem cells in clinical cell therapies (2019)
Attributed to:
Regenerative Medicine Concept Innovation Fund
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.7861/futurehosp.6-1-s76
PubMed Identifier: 31363597
Publication URI: http://europepmc.org/abstract/MED/31363597
Type: Journal Article/Review
Parent Publication: Future Healthcare Journal
Issue: Suppl 1
ISSN: 2514-6645